Clinical Trials List
2022-08-01 - 2026-08-31
Phase II
Recruiting7
ICD-10C67.9
Malignant neoplasm of bladder, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9188.9
Malignant neoplasm of bladder, part unspecified
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chi-Rei Yang Division of Urology
- Yi-Huei Chang Division of Urology
- 賴俊佑 Division of Urology
- Chao-Hsiang Chang Division of Urology
- Po-Jen Hsiao Division of Urology
- Su-Peng Yeh Division of Hematology & Oncology
- Po-Fan Hsieh Division of Urology
- Yu-De Wang Division of Urology
- Ching-Chan Lin Division of Hematology & Oncology
- Chi-Ping Huang Division of Urology
- 陳冠亨 Division of Urology
- 蔡禮賢 Division of Urology
- Che-Hung Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yi-Hsiu Huang Division of Urology
- Tzu-Ping Lin Division of Urology
- Chueh-Chuan Yen Division of Hematology & Oncology
- Hsiao-Jen Chung Division of Urology
- Tzu-Hao Huang Division of Urology
- Jiun-I Lai Division of Hematology & Oncology
- Tzu-chun Wei Division of Urology
- 陳威任 Division of Urology
- Yen-Hwa Chang Division of Urology
- Chih-Chieh Lin Division of Urology
- Jia-An Hong Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 張境夫 Division of Hematology & Oncology
- Hong-Cheng Gan Division of Hematology & Oncology
- 沈鼎文 Division of Radiology
- Yung-Chang Lin Division of Hematology & Oncology
- See-Tong Pang Division of Hematology & Oncology
- I-hung Shao Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
- Kai-Jie Yu Division of Hematology & Oncology
- Yuan-Cheng Chu Division of Hematology & Oncology
- 黃文冠 Division of Hematology & Oncology
- PO-HUNG LIN Division of Hematology & Oncology
- 黃亮鋼 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳彥豪 Division of Hematology & Oncology
- 黃詩喻 Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- 郭明濬 Division of Hematology & Oncology
- 陳彥仰 Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
- 曾亮節 Division of Radiation Therapy
- 劉建廷 Division of Hematology & Oncology
- Shau-Hsuan Li Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hung-Lung Ke Division of Urology
- 李政學 Division of Urology
- 阮雍順 Division of Urology
- Tsung-Yi Huang Division of Urology
- Ching-Chia Li Division of Urology
- Tsu-Ming Chien Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃文聰 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
- 高婉真 Division of Hematology & Oncology
- 曹朝榮 Division of Hematology & Oncology
- 林正耀 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yeong-Shiau Pu Division of Urology
- YU-CHUAN LU Division of Urology
- Ying-Chun Shen Division of Hematology & Oncology
- - - Division of Urology
- JIAN-HUA HONG Division of Urology
- JHE-CYUAN GUO Division of Hematology & Oncology
- - - Division of Urology
- PO-MING CHOW Division of Urology
- FU-JEN HSUEH Division of Hematology & Oncology
- CHUNG-HSIN CHEN Division of Urology
- YI-KAI CHANG Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
21 participants
-
Global
252 participants
